Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells
European Journal of Pharmaceutical Sciences · 2026-12 · 227 · 107656
DOI: 10.1016/j.ejps.2026.107656 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutical Sciences, 2026-12. Verfasst von Qing Cen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China. Hauptthemen laut MEDLINE: Lactoglobulins, Carcinoma, Hepatocellular, Liver Neoplasms, Antineoplastic Agents. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The development of protein-based systems capable of delivering bioactive compounds remains an important challenge in pharmaceutical formulation science. In this study, β-lactoglobulin (βLG) was investigated as a biocompatible nanocarrier for norjuziphine, 1-[(4-hydroxyphenyl)methyl]-7‑methoxy-1,2,3,4-tetrahydroisoquinolin-8-ol. The binding mechanism, protein structural changes, physicochemical characteristics, drug-release behavior, and biological performance of norjuziphine-βLG nanocomplexes were comprehensively characterized. Fluorescence quenching studies demonstrated spontaneous static complex formation with binding constants in the range of 105-106 L mol-1. Spectroscopic, calorimetric, and computational analyses consistently showed ligand-induced conformational remodeling and stabilization of βLG. The resulting nanocomplexes exhibited semi-spherical morphology with a mean hydrodynamic diameter of 190.1 ± 10.34 nm and an encapsulation efficiency of approximately 79.0%. In vitro release studies demonstrated controlled drug release behavior with moderate pH dependence. Nanoencapsulation increased intracellular norjuziphine accumulation by approximately 2.3-fold relative to free norjuziphine and was associated with enhanced antiproliferative activity in human hepatocellular carcinoma (HCC) cells, a reduced IC50 value (15.3 ± 2.33 μM), and significant regulation of Bax, Bcl-2, and Caspase-3 expression. Collectively, these findings establish a mechanistic relationship between hydrophobic interaction-driven complexation, protein conformational remodeling, and delivery performance, highlighting β-lactoglobulin as a promising protein-based carrier for improving the delivery of bioactive compounds.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of General Surgery, Cixi People's Hospital, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
- Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China.
- Cixi Biomedical Research Institute, Wenzhou Medical University, Ningbo, Zhejiang, 315300, China.
- Department of Radiotherapy Oncology, The First People's Hospital of Yancheng, Yancheng No.1 People's Hospital, Affiliated Hospital of Medical School, Nanjing University, Yancheng, 224000, China. Electronic address: 8411…
- Pingyang Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, 325400, China. Electronic address: 19588118088@163.com.
Zitieren
APA
Cen, Q., Wang, W., Pan, J., He, H., Teng, W., Wang, J., & Bai, Z. (2026). Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences, 227, 107656. https://doi.org/10.1016/j.ejps.2026.107656
Vancouver
Cen Q, Wang W, Pan J, He H, Teng W, Wang J, et al. Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells. European Journal of Pharmaceutical Sciences. 2026;227:107656. doi:10.1016/j.ejps.2026.107656
BibTeX
@article{Cen2026,
author = {Cen, Qing and Wang, Wei and Pan, Jie and He, Haibo and Teng, Weifeng and Wang, Jingzhi and Bai, Zhibin},
title = {Mechanistic characterization of norjuziphine–β-lactoglobulin nanocomplexes: Protein conformational remodeling governs encapsulation and therapeutic effects in human hepatocellular carcinoma cells},
journal = {European Journal of Pharmaceutical Sciences},
year = {2026},
volume = {227},
pages = {107656},
doi = {10.1016/j.ejps.2026.107656}
}
EUVIMED